Ignite Creation Date:
2024-05-05 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00150332
Status:
COMPLETED
Last Update Posted:
2011-05-10
First Post:
2005-09-06
Brief Title:
Linezolid for the Treatment of Infections Caused by Methicillin Resistant Staphylococcus Aureus in Japan
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Linezolid PNU-10766PNU10766SS in the Treatment of MRSA Infections in Patients Whose Conventional Therapy Has Failed or Who Are Intolerant to Conventional Therapy an Open-label Multi-center Trial
Status:
COMPLETED
Status Verified Date:
2011-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Use of linezolid in patients with methicillin-resistant Staphylococcus aureus infections in Japan
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| A5951054 | None | None | None |